Federal Awards · UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. · Award

EO14398 UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND R…

Award details are derived from public USAspending.gov records linked to this contractor. Not a bid recommendation.

Award details

Award ID
75N93021C00018
Sub-agency / office
National Institutes of Health
Award amount
$24,554,515
Period of performance
Apr 1, 2021 – Jul 31, 2028
Place of performance
ATHENS, GA, 306025016, USA
Competition
FULL AND OPEN COMPETITION · Set-aside: NO SET ASIDE USED. · 9 offers
Pricing
COST NO FEE
Financial breakdown
Current value $24,554,515 · Obligated $24,554,515 · Potential value $91,712,354 · Latest action obligation $-63,264 · Outlays $14,428,057

Public award description

EO14398 UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE

Most recent · Modification P00026 · Jul 29, 2026 · $-63,264 action obligation · EO14398 UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE · 75N93021C00018

Modification P00025 · Jul 7, 2026 · $0 action obligation · EO14398 UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE · 75N93021C00018

Modification P00024 · Apr 8, 2026 · $0 action obligation · UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE · 75N93021C00018

Modification P00023 · Mar 25, 2026 · $1,658,412 action obligation · UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE · 75N93021C00018

Modification P00022 · Dec 30, 2025 · $1,108,519 action obligation · UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE · 75N93021C00018

Modification P00021 · Sep 23, 2025 · $600,000 action obligation · UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE · 75N93021C00018

Modification P00020 · Aug 26, 2025 · $0 action obligation · UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE · 75N93021C00018

Modification P00019 · Jun 25, 2025 · $851,901 action obligation · UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE · 75N93021C00018

Modification P00018 · May 1, 2025 · $1,088,922 action obligation · UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE · 75N93021C00018

Modification P00017 · Mar 14, 2025 · $189,355 action obligation · UGA CEIRR - THIS CONTRACT WILL SUPPORT THE NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE (CEIRR) · 75N93021C00018

Modification P00016 · Mar 10, 2025 · $1,085,159 action obligation · UGA CEIRR - THIS CONTRACT WILL SUPPORT THE NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE (CEIRR) · 75N93021C00018

Modification P00015 · Sep 20, 2024 · $3,381,348 action obligation · UGA CEIRR - THIS CONTRACT WILL SUPPORT THE NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE (CEIRR) · 75N93021C00018

Modification P00014 · Jul 1, 2024 · $0 action obligation · UGA CEIRR - THIS CONTRACT WILL SUPPORT THE NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE (CEIRR) · 75N93021C00018

Modification P00013 · May 30, 2024 · $0 action obligation · UGA CEIRR - THIS CONTRACT WILL SUPPORT THE NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE (CEIRR) · 75N93021C00018

Modification P00012 · Apr 4, 2024 · $1,062,343 action obligation · UGA CEIRR - THIS CONTRACT WILL SUPPORT THE NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE (CEIRR) · 75N93021C00018

Modification P00011 · Sep 6, 2023 · $4,947,018 action obligation · UGA CEIRR - THIS CONTRACT WILL SUPPORT THE NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE (CEIRR) · 75N93021C00018

Modification P00010 · Aug 14, 2023 · $0 action obligation · UGA CEIRR - THIS CONTRACT WILL SUPPORT THE NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE (CEIRR) · 75N93021C00018

Modification P00009 · Jul 5, 2023 · $0 action obligation · UGA CEIRR - THIS CONTRACT WILL SUPPORT THE NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE (CEIRR) · 75N93021C00018

Modification P00008 · May 18, 2023 · $883,301 action obligation · UGA CEIRR - THIS CONTRACT WILL SUPPORT THE NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE (CEIRR) · 75N93021C00018

Modification P00007 · Mar 29, 2023 · $1,040,373 action obligation · UGA CEIRR - THIS CONTRACT WILL SUPPORT THE NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE (CEIRR) · 75N93021C00018

Modification P00006 · Sep 12, 2022 · $1,692,123 action obligation · THE PURPOSE OF THIS MODIFICATION IS TO EXERCISE OPTION 14, OPTION 18 AND OPTION 19.A. · 75N93021C00018

Modification P00005 · Mar 22, 2022 · $1,018,874 action obligation · THE PURPOSE OF THIS MODIFICATION IS TO EXERCISE SEVERABLE OPTION 1 FOR $1,018,874.00 AND UPDATE OTHER ARTICLES AND CLAUSES. · 75N93021C00018

Modification P00004 · Feb 4, 2022 · $0 action obligation · IPP - CEIRR UGA AWARD CONTRACT 75N93021C00018. THE PURPOSE OF THIS MODIFICATION IS TO INCORPORATE HHSAR 352.232-71 ELECTRONIC SUBMISSION OF PAYMENT REQUESTS IN FULL TEXT AND PROVIDE INSTRUCTIONS FOR THE TRANSITION FROM THE NIH OFFICE OF FINANCIAL MAN · 75N93021C00018

Modification P00003 · Oct 13, 2021 · $0 action obligation · EO14042 CEIRR UGA AWARD CONTRACT 75N93021C00018. THE PURPOSE OF THIS MODIFICATION IS TO ADD FAR DEVIATION CLAUSE 52.223-99 ENSURING ADEQUATE COVID-19 SAFETY PROTOCOLS FOR FEDERAL CONTRACTORS. · 75N93021C00018

Modification P00002 · Aug 11, 2021 · $3,010,131 action obligation · CEIRR UGA AWARD CONTRACT 75N93021C00018. THE PURPOSE OF THIS MODIFICATION IS EXERCISE THREE (3) INSTANCES OF OPTION 11 AND ONE (1) INSTANCE OF OPTION 17, UPDATE PUBLICATION DISCLOSURE REQUIREMENTS IN ARTICLE F.2 DELIVERIES AND UPDATE VARIOUS ARTICLE · 75N93021C00018

Source: USAspending.gov

Find out who's winning similar federal contracts

Discover comparable awards, related contractors, and agency purchasing history.

Recompete monitoring

Awards approaching a documented period-of-performance end date. Related forecasts or opportunities are linked only when explicit references or strong deterministic signals match — expiration alone is not a confirmed recompete.

Period ends
Jul 31, 2028 (647 days)
Evidence status
FORECAST IDENTIFIED
Evidence score
50 (deterministic, not pWin)
Forecast evidence
Matched forecast

Supporting evidence

  • FACT: Award period end date — 2028-07-31
  • FACT: Award start date — 2021-04-01
  • DERIVED: Days until period end — 647
  • FACT: Award recipient (incumbent on this award) — UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.
  • FACT: Awarding agency — Department of Health and Human Services
  • FACT: Award amount (obligated/total as stored) — 24554515

Analyze in CaptureIQ (tenant recompete watch uses your workspace data separately).

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.